13F Insight
DOSSIER · 13F-HR · Q2 2026

MAK CAPITAL ONE LLC

$714M in tracked AUM across 17 positions as of Q2 2026.

MC
CIK 0001385702 · last filed Jun 30, 2026
Total AUM
$714M
as of Q2 2026
Holdings
17
—
positions
Whale Score
75
75
strong
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Comprehensive Analysis of SEC 13F Filing: MAK CAPITAL ONE LLC

Report Period: Q3 2025 (Ended September 30, 2025) Total Portfolio Value: $306.60 Million

1. Portfolio Overview

MAK CAPITAL ONE LLC has undergone a substantial transformation in its portfolio composition during the third quarter of 2025. The firm executed a drastic reduction in portfolio size, with total assets under management (AUM) plummeting by 56.1%, declining from $698.20 million to $306.60 million. This red...

2. Key Holdings

The portfolio is characterized by extreme concentration at the top. The single largest position, Agilysys Inc (AGYS), represents a massive 52.19% of the total portfolio value, amounting to $160.01 million. This dominance suggests that the fund's performance is inextricably linked to the fortunes of this single technology holding.

The remaining top holdings provide a mix of technology and healthcare exposure, though with significantly lower weightings:

  • Autolus Therapeutics plc ($42.41M): The second-largest holding at 13.83%, representing a significant bet on the biotechnology/small-cap healthcare space.
  • PROS Holdings Inc (PRO) ($32.38M): A core technology holding comprising 10.56% of the portfolio. The firm aggressively increased this stake during the quarter, signaling strong conviction in the company’s revenue optimization software.
  • Standard Biotools Inc ($20.71M): Represents 6.76% of the portfolio and was nearly tripled in size during the quarter.
  • Grupo Supervielle S.A. ($19.80M): The sole significant financial services exposure, accounting for 6.46% of assets.
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
AGYS
AGILYSYS INC
$125M1.2M17.5%02
GGAL
GRUPO FINANCIERO GALICIA S.A
$74M1.5M10.4%03
ACHC
ACADIA HEALTHCARE COMPANY IN
$72M2.4M10.1%04
N90064101
UNIQURE NV
$57M1.2M8.0%05
SKY
CHAMPION HOMES INC
$56M632K7.8%06
AUTL
AUTOLUS THERAPEUTICS LTD
$54M33.6M7.5%07
CLPT
CLEARPOINT NEURO INC
$42M2.4M5.9%08
SUPV
GRUPO SUPERVIELLE S.A.
$41M4.3M5.8%09
CAI
CARIS LIFE SCIENCES INC
$35M1.9M4.8%10
ANNX
ANNEXON INC
$33M5.9M4.7%

Filing history

2026Q2Jun 30
$714M▲ 5.2%
17 positionsView →2026Q1Mar 31
$679M▼ 25.3%
22 positionsView →2025Q4Dec 31
$909M▲ 196.4%
23 positionsView →2025Q3Sep 30
$307M▼ 56.1%
9 positionsView →2025Q2Jun 30
$698M▲ 340.8%
16 positionsLocked2025Q1Mar 31
$158M▼ 75.8%
5 positionsLocked2024Q4Dec 31
$654M▲ 33.6%
10 positionsLocked2024Q3Sep 30
$489M▲ 17.1%
10 positionsLocked2024Q2Jun 30
$418M▼ 17.2%
9 positionsLocked2024Q1Mar 31
$504M▼ 6.7%
10 positionsLocked2023Q4Dec 31
$541M▲ 0.3%
7 positionsLocked2023Q3Sep 30
$540M▲ 2.3%
11 positionsLocked
Showing 12 of 76